Scott Terrillion

Insider Reports History

Entity
Individual
Location
C/O Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9 Th Fl, Stamford, CT
Signature
/s/ Darren DeStefano, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Terrillion:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cara Therapeutics, Inc. SEC'Y; CHIEF COMPLIANCE & G.C. Common Stock 88.2K $73.2K $0.83 Apr 5, 2024 Direct

Insider Reports Filed by Scott Terrillion

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CARA Cara Therapeutics, Inc. Apr 5, 2024 1 -$2.28K 4 Apr 9, 2024 SEC'Y; CHIEF COMPLIANCE & G.C.
CARA Cara Therapeutics, Inc. Feb 29, 2024 1 -$2.93K 4 Mar 4, 2024 SEC'Y; CHIEF COMPLIANCE & G.C.
CARA Cara Therapeutics, Inc. Feb 8, 2024 1 -$4.12K 4 Feb 12, 2024 SEC'Y; CHIEF COMPLIANCE & G.C.
CARA Cara Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 SEC'Y; CHIEF COMPLIANCE & G.C.
CARA Cara Therapeutics, Inc. Jun 23, 2023 1 -$8.72K 4 Jun 27, 2023 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Apr 4, 2023 1 -$12.2K 4 Apr 6, 2023 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Mar 3, 2023 1 -$60.7K 4 Mar 7, 2023 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Dec 21, 2022 1 -$28.9K 4 Dec 23, 2022 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Apr 1, 2022 1 -$19.6K 4 Apr 5, 2022 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Mar 3, 2022 1 -$20.3K 4 Mar 4, 2022 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Feb 25, 2022 4 -$20.3K 4 Mar 1, 2022 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Dec 17, 2021 1 $0 4 Dec 21, 2021 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Aug 30, 2021 1 -$25K 4 Sep 1, 2021 Sec'y; Chief Compliance & G.C.
CARA Cara Therapeutics, Inc. Aug 24, 2021 1 $0 4 Aug 26, 2021 Sec'y; Chief Compliance & G.C.